BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 23763474)

  • 1. Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral Carcinogenesis.
    Bates T; Kennedy M; Diajil A; Goodson M; Thomson P; Doran E; Farrimond H; Thavaraj S; Sloan P; Kist R; Robinson M
    Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):927-35. PubMed ID: 27197272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma.
    Begum A; Imoto I; Kozaki K; Tsuda H; Suzuki E; Amagasa T; Inazawa J
    Cancer Sci; 2009 Oct; 100(10):1908-16. PubMed ID: 19594544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines.
    Ludwig ML; Kulkarni A; Birkeland AC; Michmerhuizen NL; Foltin SK; Mann JE; Hoesli RC; Devenport SN; Jewell BM; Shuman AG; Spector ME; Carey TE; Jiang H; Brenner JC
    Oral Oncol; 2018 Dec; 87():144-151. PubMed ID: 30527230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting EGFR gene amplification using a fluorescence in situ hybridization platform based on digital microfluidics.
    Shen C; Zhan C; Tong Z; Yin H; Hui J; Qiu S; Li Q; Xu X; Ma H; Wu Z; Shi N; Mao H
    Talanta; 2024 Mar; 269():125444. PubMed ID: 38042143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Biomarker Assays for
    Lassman AB; Roberts-Rapp L; Sokolova I; Song M; Pestova E; Kular R; Mullen C; Zha Z; Lu X; Gomez E; Bhathena A; Maag D; Kumthekar P; Gan HK; Scott AM; Guseva M; Holen KD; Ansell PJ; van den Bent MJ
    Clin Cancer Res; 2019 Jun; 25(11):3259-3265. PubMed ID: 30796037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma.
    Ura A; Hayashi T; Komura K; Hosoya M; Takamochi K; Sato E; Saito S; Wakai S; Handa T; Saito T; Kato S; Suzuki K; Yao T;
    J Pathol Clin Res; 2024 Jan; 10(1):e350. PubMed ID: 37974379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of epidermal growth factor receptor in histological, clinical and pathological staging of oral squamous cell carcinoma.
    Umarani PJ; Rudresh KB; Smitha T; Rajaram P
    J Oral Maxillofac Pathol; 2022; 26(3):362-365. PubMed ID: 36588836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of EGFR and p16 in Squamous Cell Carcinoma of External Auditory Canal.
    Kajimoto Y; Shinomiya H; Uehara N; Teshima M; Fujita T; Kakigi A; Imamura Y; Kiyota N; Miyawaki D; Sasaki R; Kimura H; Nibu KI
    Kobe J Med Sci; 2024 Jan; 69(4):E144-E150. PubMed ID: 38379276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration status and prognostic value of MET in head and neck squamous cell carcinoma.
    Cho YA; Kim EK; Heo SJ; Cho BC; Kim HR; Chung JM; Yoon SO
    J Cancer; 2016; 7(15):2197-2206. PubMed ID: 27994655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma.
    Palumbo C; Benvenuto M; Focaccetti C; Albonici L; Cifaldi L; Rufini A; Nardozi D; Angiolini V; Bei A; Masuelli L; Bei R
    Front Med (Lausanne); 2023; 10():1066021. PubMed ID: 36817764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination RSL3 Treatment Sensitizes Ferroptosis- and EGFR-Inhibition-Resistant HNSCCs to Cetuximab.
    Liu S; Yan S; Zhu J; Lu R; Kang C; Tang K; Zeng J; Ding M; Guo Z; Lai X; Jiang Y; Wu S; Zhou L; Sun L; Zhou ZW
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer.
    Jeon YK; Sung SW; Chung JH; Park WS; Seo JW; Kim CW; Chung DH
    Lung Cancer; 2006 Dec; 54(3):387-98. PubMed ID: 17011067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.
    Huang SF; Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM
    BMC Cancer; 2017 Aug; 17(1):592. PubMed ID: 28854970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR polysomy in squamous cell carcinoma of the thyroid. Report of two cases and review of the literature.
    Bonetti LR; Lupi M; Trani M; Trani N; Sartori G; Schirosi L; Bettelli S; Zanelli G; Maccio L; Maiorana A
    Tumori; 2010; 96(3):503-7. PubMed ID: 20845818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecules in the Treatment of Squamous Cell Carcinomas: Focus on Indirubins.
    Schäfer M; Semmler ML; Bernhardt T; Fischer T; Kakkassery V; Ramer R; Hein M; Bekeschus S; Langer P; Hinz B; Emmert S; Boeckmann L
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR expression and copy number changes in low T-stage oral squamous cell carcinomas.
    Rössle M; Weber CS; Züllig L; Graf N; Jochum W; Stöckli SJ; Moch H; Huber GF
    Histopathology; 2013 Aug; 63(2):271-8. PubMed ID: 23763474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.